Skip to Main Content

Paper Details

Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice.
Proc Natl Acad Sci U S A
64
2021
501Y.V1/, ACE2, COVID-19, RBD, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 receptor binding domain, Wuhan-Hu-1 variant, mice, yeast
Author NameAffiliation
Lauren CarterUniversity of Washington
Lauren CarterInstitute for Protein Design, University of Washington
Charles A WhittakerThe Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Brooke FialaUniversity of Washington
Brooke FialaInstitute for Protein Design, University of Washington
Harry KleanthousBill & Melinda Gates Foundation
Neil P KingUniversity of Washington
Neil P KingInstitute for Protein Design, University of Washington
Dan H BarouchRagon Institute of Massachusetts General Hospital (MGH)
Dan H BarouchCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School
Dan H Barouch
  • 1 - 11

Datasets

Release 1.2